Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived

Registro en:

0306-9877

https://www.sciencedirect.com/science/article/pii/S0306987720311208?via%3Dihub#kg005

http://hdl.handle.net/20.500.12010/10992

https://doi.org/10.1016/j.mehy.2020.109865

http://repositorioslatinoamericanos.uchile.cl/handle/2250/3502302

Autor

Taghavi-Farahabadi, Mahsa

Mahmoudi, Mohammad

Soudi, Sara

Hashemi, Seyed Mahmoud

Institución

Universidad Jorge Tadeo Lozano (Colombia)

Materias

Acute respiratory distress syndrome

Mesenchymal stem cell

Mostrar el registro completo del ítem